IMRX
Price
$5.51
Change
+$0.05 (+0.92%)
Updated
Sep 5 closing price
Capitalization
229.05M
60 days until earnings call
SRRK
Price
$31.41
Change
-$1.03 (-3.18%)
Updated
Sep 5 closing price
Capitalization
3.02B
71 days until earnings call
Interact to see
Advertisement

IMRX vs SRRK

Header iconIMRX vs SRRK Comparison
Open Charts IMRX vs SRRKBanner chart's image
Immuneering
Price$5.51
Change+$0.05 (+0.92%)
Volume$594.02K
Capitalization229.05M
Scholar Rock Holding
Price$31.41
Change-$1.03 (-3.18%)
Volume$2.11M
Capitalization3.02B
IMRX vs SRRK Comparison Chart in %
Loading...
IMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMRX vs. SRRK commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMRX is a StrongBuy and SRRK is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (IMRX: $5.51 vs. SRRK: $31.41)
Brand notoriety: IMRX and SRRK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMRX: 76% vs. SRRK: 133%
Market capitalization -- IMRX: $229.05M vs. SRRK: $3.02B
IMRX [@Biotechnology] is valued at $229.05M. SRRK’s [@Biotechnology] market capitalization is $3.02B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMRX’s FA Score shows that 0 FA rating(s) are green whileSRRK’s FA Score has 0 green FA rating(s).

  • IMRX’s FA Score: 0 green, 5 red.
  • SRRK’s FA Score: 0 green, 5 red.
According to our system of comparison, SRRK is a better buy in the long-term than IMRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMRX’s TA Score shows that 5 TA indicator(s) are bullish while SRRK’s TA Score has 4 bullish TA indicator(s).

  • IMRX’s TA Score: 5 bullish, 5 bearish.
  • SRRK’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, IMRX is a better buy in the short-term than SRRK.

Price Growth

IMRX (@Biotechnology) experienced а -4.17% price change this week, while SRRK (@Biotechnology) price change was -3.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

IMRX is expected to report earnings on Nov 06, 2025.

SRRK is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRRK($3.02B) has a higher market cap than IMRX($229M). IMRX YTD gains are higher at: 150.455 vs. SRRK (-27.325). IMRX has higher annual earnings (EBITDA): -63.7M vs. SRRK (-320.22M). SRRK has more cash in the bank: 295M vs. IMRX (26.4M). IMRX has less debt than SRRK: IMRX (4M) vs SRRK (61.5M). IMRX (0) and SRRK (0) have equivalent revenues.
IMRXSRRKIMRX / SRRK
Capitalization229M3.02B8%
EBITDA-63.7M-320.22M20%
Gain YTD150.455-27.325-551%
P/E RatioN/AN/A-
Revenue00-
Total Cash26.4M295M9%
Total Debt4M61.5M7%
FUNDAMENTALS RATINGS
SRRK: Fundamental Ratings
SRRK
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
78
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMRXSRRK
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
89%
Advances
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 5 days ago
82%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
80%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
IMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KNYJF60.05N/A
N/A
Kone Oyj
LMGHF2.10N/A
N/A
VICTORY PARTN VIII NORWAY HLDG AS
PBIGF0.17N/A
N/A
Paradigm Biopharmaceuticals Ltd.
YATRY16.72N/A
N/A
Yamato Holdings Co., Ltd.
ENTEF0.06N/A
-1.38%
ESE Entertainment Inc.

IMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMRX has been loosely correlated with NUVL. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if IMRX jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMRX
1D Price
Change %
IMRX100%
+0.92%
NUVL - IMRX
35%
Loosely correlated
+1.53%
SRRK - IMRX
31%
Poorly correlated
-3.18%
ENTBF - IMRX
31%
Poorly correlated
N/A
INSM - IMRX
30%
Poorly correlated
+1.80%
DNA - IMRX
29%
Poorly correlated
-4.54%
More

SRRK and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRRK has been loosely correlated with PLRX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if SRRK jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRRK
1D Price
Change %
SRRK100%
-3.18%
PLRX - SRRK
40%
Loosely correlated
+14.11%
SNDX - SRRK
39%
Loosely correlated
+5.25%
VTGN - SRRK
39%
Loosely correlated
-1.93%
ENTO - SRRK
38%
Loosely correlated
+1.89%
ALT - SRRK
37%
Loosely correlated
+6.18%
More